Search Results 731-740 of 24216 for In situ

1. Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) - Mayo Clinic

   Presence of a malignant disease within the last 12 months, with the exception of adequately treated in-situ carcinomas, basal or squamous cell carcinoma, or ...

2. Cabozantinib and Nivolumab in Treating Patients With Advanced, Recurrent or Metastatic Endometrial Cancer - Mayo Clinic

   ... in situ of any site. Patients with known brain metastases should be excluded from this clinical trial. Patients requiring concomitant treatment, in ...

3. Publications - Amy A. Swanson, M.D. - Mayo Clinic

   ... In Situ Hybridization Analysis. Int J Gynecol Pathol. 2025 Jul 1; 44 (4):355-357 Epub 2024 July 23. View PubMed; Dashti NK, Swanson AA, Keeney GL, Edgar MA ...

4. Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma - Mayo Clinic

   In addition: to determine the impact of polyamine depletion on polyamine abundance and the global extracellular metabolome within live human gliomas, in situ ...

5. Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery - Mayo Clinic

   Drugs used in chemotherapy, such as ifosfamide and doxorubicin hydrochloride, work in ... any carcinoma-in-situ or prostate cancer with low risk factors.

6. A Study to Evaluate At Home Administration of Pertuzumab Combined with Trastuzumab to Treat Patients with HER2-Positive Breast Cancer During COVID-19 Pandemic - Mayo Clinic

   Appropriately treated non-melanoma skin cancer; in situ carcinomas, including cervix, colon, or skin; or Stage I uterine cancer within the last 5 years are ...

7. Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors - Mayo Clinic

   The purpose of this study is to see how well cabozantinib S-malate works compared with placebo in ... situ; patients are not considered to have a ... Except in the ...

8. A Study to Assess the Effectiveness and Safety of UGN-102 as a Primary Chemoablation Agent in Patients with Low Grade Non-Muscle-Invasive Bladder Cancer (LG NMIBC) at Intermediate Risk of Recurrence - Mayo Clinic

   A Study to Assess the Effectiveness and Safety of UGN-102 as a Primary Chemoablation Agent in ... History of Carcinoma in Situ (CIS) on preliminary cystoscopy ...

9. Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy in the Lung - Mayo Clinic

   OCT can differentiate carcinoma in situ versus microinvasive cancer. Endoscopic optical imaging is a promising technology that can expand the horizon for ...

10. An Efficacy Study Comparing Oral Ixazomib/Dexamethasone and Oral Pomalidomide/Dexamethasone in Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    Patients with nonmelanoma skin cancer or carcinoma in situ of any type are not excluded if they have undergone complete resection. Diagnosis of smoldering ...